Please login to the form below

Not currently logged in

Sanofi-aventis investigated by European Commission

The European Commission has launched an anti-trust investigation into pharmaceutical company sanofi-aventis
The European Commission (EC) has launched an anti-trust investigation into pharmaceutical company sanofi-aventis.

The Commission claims that the firm refused to allow officials to examine or copy documents without a search warrant, which was subsequently produced, from the French authorities.

During the inspection of the company's premises, commission officials along with officers from the French competition authority, identified documents that were relevant to the competition sector inquiry.

This inspection is part of an ongoing inquiry into the potential misuse of the patent system by pharmaceutical companies to delay market entry of competing generic drugs, including those for treating or preventing disease in humans. An initiation of proceedings does not imply that the commission has proof of an infringement.

"Individuals and governments want a strong pharmaceuticals sector that delivers better products and value for money," said competition commissioner, Neelie Kroes, commenting on the launch of the EC's investigations in January this year.

"But if innovative products are not being produced, and cheaper generic alternatives to existing products are in some cases being delayed, then we need to find out why and, if necessary, take action," she added.

3rd June 2008


Featured jobs

Subscribe to our email news alerts


Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...